BE550650A
(es)
|
1955-08-30 |
|
|
|
JPS4916937B1
(es)
|
1970-01-21 |
1974-04-25 |
|
|
US3823240A
(en)
|
1970-10-06 |
1974-07-09 |
Rhone Poulenc Sa |
Fungicidal hydantoin derivatives
|
GB1472467A
(en)
|
1974-04-19 |
1977-05-04 |
Wyeth John & Brother Ltd |
Thiohydantoins
|
FR2329276A1
(fr)
|
1975-10-29 |
1977-05-27 |
Roussel Uclaf |
Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
|
DE2614831A1
(de)
|
1976-04-06 |
1977-10-20 |
Bayer Ag |
1,3,4-thiadiazolylderivate, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
|
MC1220A1
(fr)
|
1977-10-28 |
1979-07-20 |
Hoffmann La Roche |
Nouveaux derives d'imidazolidine
|
CA1138334A
(en)
|
1977-10-28 |
1982-12-28 |
Karl Bernauer |
Pharmaceutical preparations containing certain urea derivatives
|
ZA786739B
(en)
|
1977-12-01 |
1980-07-30 |
Wellcome Found |
Hydantoin derivatives and salts thereof,their syntheses,and intermediates,and pharmaceutical formulations
|
EP0004723A1
(en)
|
1978-03-30 |
1979-10-17 |
Beecham Group Plc |
Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them
|
FR2449448B1
(fr)
|
1979-02-20 |
1983-05-27 |
Inst Nat Radio Elements |
Composition pharmaceutique comprenant un derive de phenylhydantoine, derives mis en oeuvre et leur preparation
|
FI801184A
(fi)
|
1979-04-24 |
1980-10-25 |
Hoffmann La Roche |
Foerfarande foer framstaellning av imidazolidinderivat
|
US4229447A
(en)
|
1979-06-04 |
1980-10-21 |
American Home Products Corporation |
Intraoral methods of using benzodiazepines
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
JPS57197268A
(en)
|
1981-05-29 |
1982-12-03 |
Sumitomo Chem Co Ltd |
Substituted phenylhydantoin derivative, its preparation, and herbicide containing the same as active ingredient
|
EP0091596B1
(de)
|
1982-04-08 |
1991-09-11 |
Shell Internationale Researchmaatschappij B.V. |
Neue Hydantoine, ihre Herstellung und Verwendung
|
US4473393A
(en)
|
1982-08-06 |
1984-09-25 |
Buffalo Color Corporation |
Pesticidal thiohydantoin compositions
|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
JPS59210083A
(ja)
|
1983-05-13 |
1984-11-28 |
Otsuka Chem Co Ltd |
1,3,4−チアジアゾ−ル−5−オン誘導体、その製造法及び該誘導体を有効成分とする除草剤
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
JPS6092285A
(ja)
|
1983-10-26 |
1985-05-23 |
Shionogi & Co Ltd |
イソオキサゾ−ル系環状尿素類
|
US4596795A
(en)
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
JPS60239737A
(ja)
|
1984-05-14 |
1985-11-28 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀写真感光材料
|
JPH0219363Y2
(es)
|
1985-07-31 |
1990-05-29 |
|
|
JPH0778017B2
(ja)
|
1985-12-28 |
1995-08-23 |
住友製薬株式会社 |
パルス的かつ持続放出性製剤
|
US4755386A
(en)
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
DE3604042A1
(de)
|
1986-02-08 |
1987-08-13 |
Hoechst Ag |
Imidazolidin(thi)on-derivate, verfahren zu ihrer herstellung sowie ihre verwendung im pflanzenschutz
|
US5071773A
(en)
|
1986-10-24 |
1991-12-10 |
The Salk Institute For Biological Studies |
Hormone receptor-related bioassays
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
JPS649978A
(en)
|
1987-07-02 |
1989-01-13 |
Shionogi & Co |
Perfluoroalkylisoxazole derivative
|
US4859228A
(en)
|
1987-07-16 |
1989-08-22 |
Ici Americas Inc |
Novel 5-aminomethylene-2,4-imidazolidinediones and 5-aminomethylene-2-thionoimidazolidine-4-ones
|
US5010182A
(en)
|
1987-07-28 |
1991-04-23 |
Chiron Corporation |
DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
|
FR2619381B1
(fr)
|
1987-08-13 |
1989-12-08 |
Roussel Uclaf |
Nouvelles imidazolidines substituees par un radical hydroxymethyle et un radical phenyl substitue, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant et un intermediaire pour leur preparation
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
CA1331757C
(en)
|
1988-02-29 |
1994-08-30 |
Janssen Pharmaceutica Naamloze Vennootschap |
5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
|
US5614620A
(en)
|
1988-03-30 |
1997-03-25 |
Arch Development Corporation |
DNA binding proteins including androgen receptor
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
US6307030B1
(en)
|
1988-04-15 |
2001-10-23 |
The University Of North Carolina At Chapel Hill |
Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
|
JPH0219363A
(ja)
|
1988-07-06 |
1990-01-23 |
Fujisawa Pharmaceut Co Ltd |
イミダゾリジン誘導体
|
AU4005289A
(en)
|
1988-08-25 |
1990-03-01 |
Smithkline Beecham Corporation |
Recombinant saccharomyces
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
DE3835168A1
(de)
|
1988-10-15 |
1990-04-19 |
Bayer Ag |
N-aryl-stickstoffheterocyclen, mehrere verfahren zu ihrer herstellung und ihre verwendung als herbizide
|
FR2646437B1
(fr)
|
1989-04-28 |
1991-08-30 |
Transgene Sa |
Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
|
US5739136A
(en)
|
1989-10-17 |
1998-04-14 |
Ellinwood, Jr.; Everett H. |
Intraoral dosing method of administering medicaments
|
FR2656302B1
(fr)
|
1989-12-22 |
1992-05-07 |
Roussel Uclaf |
Nouveau procede de preparation de l'anandron et derives de l'anandron.
|
US5017381A
(en)
|
1990-05-02 |
1991-05-21 |
Alza Corporation |
Multi-unit pulsatile delivery system
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
USRE35956E
(en)
|
1991-01-09 |
1998-11-10 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
FR2693461B1
(fr)
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
FR2671348B1
(fr)
|
1991-01-09 |
1993-03-26 |
Roussel Uclaf |
Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
|
JP2845384B2
(ja)
|
1991-11-14 |
1999-01-13 |
キヤノン株式会社 |
画像処理装置
|
US5229135A
(en)
|
1991-11-22 |
1993-07-20 |
Prographarm Laboratories |
Sustained release diltiazem formulation
|
US5346913A
(en)
|
1992-05-26 |
1994-09-13 |
Rohm And Haas Company |
N-iodopropargyl hydantoin compounds, compositions, preparation, and use as antimicrobial agents
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
FR2694290B1
(fr)
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
DE4316542C1
(de)
|
1993-05-18 |
1994-07-21 |
Schaefer Micomed Gmbh |
Osteosynthesevorrichtung
|
TW521073B
(en)
|
1994-01-05 |
2003-02-21 |
Hoechst Marion Roussel Inc |
New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
|
FR2715402B1
(fr)
|
1994-01-05 |
1996-10-04 |
Roussel Uclaf |
Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
CA2181358A1
(en)
|
1994-01-21 |
1995-07-27 |
Nancy M. Gray |
Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
|
US6124211A
(en)
|
1994-06-14 |
2000-09-26 |
Fsi International, Inc. |
Cleaning method
|
JPH089997A
(ja)
|
1994-06-28 |
1996-01-16 |
Shimadzu Corp |
核酸合成法およびそれに用いる試薬キット
|
DE69519921T2
(de)
|
1994-07-29 |
2001-06-13 |
Suntory Limited, Osaka |
Imidazolidin-derivate und ihre verwendung
|
FR2725206B1
(fr)
|
1994-09-29 |
1996-12-06 |
Roussel Uclaf |
Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
|
US5656651A
(en)
|
1995-06-16 |
1997-08-12 |
Biophysica Inc. |
Androgenic directed compositions
|
DE19540027A1
(de)
|
1995-10-27 |
1997-04-30 |
Gruenenthal Gmbh |
Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
|
FR2741346B1
(fr)
|
1995-11-16 |
1997-12-19 |
Roussel Uclaf |
Nouveau procede de preparation de derives phenylimidazolidine
|
FR2741342B1
(fr)
|
1995-11-22 |
1998-02-06 |
Roussel Uclaf |
Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
|
WO1997019931A1
(en)
|
1995-11-28 |
1997-06-05 |
American Home Products Corporation |
2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives
|
TW418195B
(en)
|
1995-11-28 |
2001-01-11 |
American Home Prod |
2-thioxo-imidazolidin-4-one derivatives
|
US5554607A
(en)
|
1995-11-28 |
1996-09-10 |
American Home Products Corporation |
Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
US5780435A
(en)
|
1995-12-15 |
1998-07-14 |
Praecis Pharmaceuticals Incorporated |
Methods for treating prostate cancer with LHRH-R antagonists
|
FR2742749B1
(fr)
|
1995-12-22 |
1998-02-06 |
Roussel Uclaf |
Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques
|
US6489163B1
(en)
|
1996-05-08 |
2002-12-03 |
Board Of Regents, The University Of Texas System |
Ribozyme mediated inactivation of the androgen receptor
|
JP3697320B2
(ja)
|
1996-06-20 |
2005-09-21 |
株式会社日立製作所 |
光ファイバセンサ
|
CN1216636C
(zh)
|
1996-08-30 |
2005-08-31 |
派普泰克有限公司 |
肽缓释组合物
|
US5726061A
(en)
|
1996-10-08 |
1998-03-10 |
Smithkline Beechum Corporation |
Method of diagnosing and monitoring colorectal cancer
|
US7053263B2
(en)
|
1996-10-15 |
2006-05-30 |
The Regents Of The University Of California |
Mouse models of human prostate cancer progression
|
WO1998033772A1
(en)
|
1997-02-03 |
1998-08-06 |
Dow Agrosciences Llc |
2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with carboxylic acid derivatives on the pyridine ring as fungicides
|
US5840329A
(en)
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
US6506607B1
(en)
|
1997-12-24 |
2003-01-14 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer
|
AU4562799A
(en)
|
1998-06-15 |
2000-01-05 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
EP0989122B1
(de)
|
1998-09-22 |
2003-05-21 |
Degussa AG |
Verfahren zur Herstellung von Imidazolidin-2,4-dionen
|
CA2345146C
(en)
|
1998-09-22 |
2010-02-23 |
Yamanouchi Pharmaceutical Co., Ltd. |
Cyanophenyl derivative
|
AU1308400A
(en)
|
1998-10-30 |
2000-05-22 |
G.D. Searle & Co. |
Novel amino acid heterocyclic amide derivatives useful as nitric oxide synthase inhibitors
|
US6472415B1
(en)
|
1998-12-18 |
2002-10-29 |
Biophysica, Inc. |
Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
|
AU2847200A
(en)
|
1999-01-27 |
2000-08-18 |
G.D. Searle & Co. |
Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
|
WO2001007048A1
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
US6479063B2
(en)
|
1999-12-27 |
2002-11-12 |
Kenneth Weisman |
Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis
|
GB0008368D0
(en)
|
2000-04-06 |
2000-05-24 |
Astrazeneca Ab |
Combination product
|
US6570025B1
(en)
|
2000-05-31 |
2003-05-27 |
Mitsui Chemicals, Inc. |
Sulfur compound and use thereof
|
PT1284973E
(pt)
|
2000-05-31 |
2007-08-17 |
Tanabe Seiyaku Co |
''inibidores de adesão celular mediada por alfa l beta 2''
|
US6482829B2
(en)
|
2000-06-08 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor
|
US20040077605A1
(en)
|
2001-06-20 |
2004-04-22 |
Salvati Mark E. |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
WO2002053155A1
(en)
|
2000-12-30 |
2002-07-11 |
Geron Corporation |
Telomerase inhibitor
|
FR2823209B1
(fr)
|
2001-04-04 |
2003-12-12 |
Fournier Lab Sa |
Nouvelles thiohydantoines et leur utilisation en therapeutique
|
US6710037B2
(en)
|
2001-05-01 |
2004-03-23 |
Schering Corporation |
Method of treating androgen-dependent disorders
|
NZ531870A
(en)
|
2001-10-01 |
2005-08-26 |
Bristol Myers Squibb Co |
Spiro-hydantoin compounds useful as anti-inflammatory agents
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
US6861432B2
(en)
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
GB0200283D0
(en)
|
2002-01-08 |
2002-02-20 |
Smithkline Beecham Plc |
Compounds
|
DE10218963A1
(de)
|
2002-04-27 |
2003-11-20 |
Aventis Pharma Gmbh |
Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
|
TW200407324A
(en)
|
2002-05-17 |
2004-05-16 |
Bristol Myers Squibb Co |
Bicyclic modulators of androgen receptor function
|
US20060127902A1
(en)
|
2002-08-15 |
2006-06-15 |
Genzyme Corporation |
Brain endothelial cell expression patterns
|
AU2002951247A0
(en)
|
2002-09-06 |
2002-09-19 |
Alchemia Limited |
Compounds that interact with kinases
|
FR2845384B1
(fr)
|
2002-10-04 |
2004-12-31 |
Fournier Lab Sa |
Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique
|
FR2845385B1
(fr)
|
2002-10-04 |
2004-12-31 |
Fournier Lab Sa |
Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique
|
EP1558231A4
(en)
|
2002-10-03 |
2010-09-08 |
Cypress Bioscience Inc |
DOSAGE CLIMBING AND FRICTIONAL DAILY DOSE OF ANTIDEPRESSANTS TO TREAT NEUROLOGICAL DISORDERS
|
AU2003279442A1
(en)
|
2002-10-04 |
2004-04-23 |
Laboratoires Fournier S.A. |
2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
|
FR2850652B1
(fr)
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
JP2004252175A
(ja)
|
2003-02-20 |
2004-09-09 |
Kyocera Mita Corp |
現像装置、画像形成装置および現像剤の回収方法
|
JP4664814B2
(ja)
|
2003-06-12 |
2011-04-06 |
中外製薬株式会社 |
イミダゾリジン誘導体
|
KR20060017791A
(ko)
|
2003-06-12 |
2006-02-27 |
노보 노르디스크 에이/에스 |
호르몬-민감성 리파제 억제제로서의 피리디닐 카르바메이트
|
RU2333198C2
(ru)
|
2003-06-12 |
2008-09-10 |
Астеллас Фарма Инк. |
Производные бензамида или фармацевтически приемлемые соли указанного производного, фармацевтическая композиция на их основе и применение
|
PE20050444A1
(es)
|
2003-10-31 |
2005-08-09 |
Takeda Pharmaceutical |
Compuestos de piridina como inhibidores de la peptidasa
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
EP1709152A4
(en)
|
2003-12-15 |
2007-11-07 |
Univ California |
MOLECULAR SIGNATURE OF PTEN TUMOR SUPPRESSOR
|
AU2004305075A1
(en)
|
2003-12-19 |
2005-07-07 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies
|
NZ550102A
(en)
|
2004-02-24 |
2010-10-29 |
Univ California |
Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
|
CN1960725A
(zh)
|
2004-03-15 |
2007-05-09 |
Ptc医疗公司 |
用于抑制血管发生的四环咔啉衍生物
|
EP1621536A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
EP1621539A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
TW200612920A
(en)
|
2004-08-03 |
2006-05-01 |
Chugai Pharmaceutical Co Ltd |
Novel imidazolidine derivatives
|
US8470829B2
(en)
|
2004-09-09 |
2013-06-25 |
Chugai Seiyaku Kabushiki Kaisha |
Imidazolidine derivative and use thereof
|
KR101363563B1
(ko)
|
2004-09-10 |
2014-02-14 |
자고텍 아게 |
활성성분의 부위 및 시간 제어적 위장관 방출 정제
|
KR20070108259A
(ko)
|
2005-03-23 |
2007-11-08 |
화이자 프로덕츠 인크. |
Ctla-4 항체와 호르몬 요법에 의한 전립선암의 치료법
|
US7709517B2
(en)
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
PT2444085E
(pt)
|
2005-05-13 |
2015-06-11 |
Univ California |
Compostos de diaril-hidantoínas como antagonistas do recetor androgénio para tratamento de cancro
|
FR2889189A1
(fr)
|
2005-07-28 |
2007-02-02 |
Cerep Sa |
Composes derives d'hydantoine et leur utilistion en tant qu'antagonistes de mchr-1
|
GB0521373D0
(en)
|
2005-10-20 |
2005-11-30 |
Kudos Pharm Ltd |
Pthalazinone derivatives
|
CN101032486B
(zh)
|
2006-03-08 |
2011-05-11 |
张宏 |
逆转唑类药物抗真菌活性多药耐药性的药用植物增效剂
|
CN101032483B
(zh)
|
2006-03-09 |
2011-05-04 |
陈德桂 |
调节雄激素受体活性的乙内酰脲衍生物及其应用
|
PL2656841T3
(pl)
|
2006-03-27 |
2017-01-31 |
The Regents Of The University Of California |
Modulator receptora androgenowego do leczenia raka gruczołu krokowego i chorób związanych z receptorem androgenowym
|
EP2439196A1
(en)
|
2006-03-29 |
2012-04-11 |
The Regents of The University of California |
Diarylthiohydantoin compounds for use in a method for the treatment of a hyperproliferative disorder
|
EP1891964A1
(en)
|
2006-08-08 |
2008-02-27 |
AEterna Zentaris GmbH |
Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
|
KR20150108946A
(ko)
|
2006-08-25 |
2015-09-30 |
코우가 바이오테크놀로지, 인크. |
암을 치료하기 위한 방법 및 조성물
|
EP2063963A2
(en)
|
2006-08-25 |
2009-06-03 |
Cougar Biotechnology, Inc. |
Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent
|
EP1905439A1
(en)
|
2006-09-24 |
2008-04-02 |
GPC Biotech AG |
Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
|
JP4993996B2
(ja)
|
2006-10-20 |
2012-08-08 |
フクダ電子株式会社 |
輸液ポンプモニタリング装置
|
WO2008119015A2
(en)
|
2007-03-27 |
2008-10-02 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of thiohydantoins
|
EP2620432A3
(en)
|
2007-10-26 |
2013-12-18 |
The Regents Of the University of California |
Diarylhydantoin compounds
|
EP2222286A1
(en)
|
2007-11-09 |
2010-09-01 |
Novartis AG |
Corticosteroids to treat epothilone or epothilone derivative induced diarrhea
|
JOP20090061B1
(ar)
|
2008-02-11 |
2021-08-17 |
Ferring Int Center Sa |
طريقة معالجة سرطان البروستاتا بمضادات الهرمونات التناسلية GnRH
|
US20140187641A1
(en)
*
|
2012-08-23 |
2014-07-03 |
Gtx |
Estrogen receptor ligands and methods of use thereof
|
AU2010218052A1
(en)
|
2009-02-24 |
2011-09-08 |
Medivation Prostate Therapeutics, Inc. |
Specific diarylhydantoin and diarylthiohydantoin compounds
|
WO2010124826A1
(en)
*
|
2009-04-29 |
2010-11-04 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted imidazoquinoxalines
|
SG10201907588XA
(en)
|
2010-02-16 |
2019-09-27 |
Aragon Pharmaceuticals Inc |
Androgen Receptor Modulators And Uses Thereof
|
PL2538785T3
(pl)
|
2010-02-24 |
2018-08-31 |
Medivation Prostate Therapeutics Llc |
Sposoby syntezy zwiazków diarylotiohydantoinowych i diarylohydantoinowych
|
KR101926320B1
(ko)
|
2010-08-04 |
2018-12-06 |
펠피큐어 파마슈티걸즈 아이엔씨 |
전립선 암종의 치료를 위한 병용 요법
|
EP2606130B1
(en)
*
|
2010-08-16 |
2019-03-13 |
Duke University |
Camkk-beta as a marker in prostate cancer
|
US9314473B2
(en)
*
|
2011-02-03 |
2016-04-19 |
Pop Test Oncology Limited Liability Company |
System and method for diagnosis and treatment
|
WO2012142208A1
(en)
|
2011-04-13 |
2012-10-18 |
The Trustees Of The University Of Pennsylvania |
Bifunctional akr1c3 inhibitors/androgen receptor modulators and methods of use thereof
|
WO2012145330A1
(en)
|
2011-04-18 |
2012-10-26 |
The University Of British Columbia |
Fluorene-9-bisphenol compounds and methods for their use
|
EP2709614A4
(en)
*
|
2011-05-17 |
2015-04-15 |
Takeda Pharmaceutical |
PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF CANCER
|
EP3430907A1
(en)
|
2011-07-29 |
2019-01-23 |
Medivation Prostate Therapeutics LLC |
Treatment of breast cancer
|
EP2744773B1
(en)
*
|
2011-08-19 |
2016-11-02 |
British Columbia Cancer Agency Branch |
Fluorinated bisphenol ether compounds and methods for their use
|
US20130079241A1
(en)
*
|
2011-09-15 |
2013-03-28 |
Jianhua Luo |
Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse
|
MY175800A
(en)
*
|
2011-11-30 |
2020-07-09 |
Astrazeneca Ab |
Combination treatment of cancer
|
EP2817019A4
(en)
|
2012-02-24 |
2016-04-06 |
Univ Chicago |
METHODS AND COMPOSITIONS ASSOCIATED WITH GLUCOCORTICOID RECEPTOR ANTAGONISM AND PROSTATE CANCER
|
WO2013152342A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Anti-cancer mtor inhibitor and anti-androgen combination
|
FR2989357B1
(fr)
|
2012-04-12 |
2016-02-05 |
Allia |
Conditionnement unique pour un ensemble sanitaire comprenant une cuvette de wc suspendu et un bati-support associe
|
ES2670683T3
(es)
|
2012-06-07 |
2018-05-31 |
Aragon Pharmaceuticals, Inc. |
Formas cristalinas de un modulador de receptor de andrógenos
|
HUE057701T2
(hu)
|
2012-09-11 |
2022-05-28 |
Medivation Prostate Therapeutics Llc |
Enzalutamid kiszerelési formái
|
ES2836424T3
(es)
|
2012-09-26 |
2021-06-25 |
Aragon Pharmaceuticals Inc |
Antiandrógenos para tratar el cáncer de próstata no metastásico y resistente a la castración
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
EP2988824B1
(en)
|
2013-04-23 |
2018-11-07 |
Zx Pharma, Llc |
Enteric coated multiparticulate composition with proteinaceous subcoat
|
KR20160085915A
(ko)
|
2013-12-06 |
2016-07-18 |
에프. 호프만-라 로슈 아게 |
국소 진행성 또는 전이성 에스트로겐 수용체 양성 유방암을 치료하기 위한 에스트로겐 수용체 조절자
|
CN106999432A
(zh)
|
2014-12-05 |
2017-08-01 |
阿拉贡药品公司 |
抗癌组合物
|
MA41107A
(fr)
|
2014-12-05 |
2017-10-10 |
Aragon Pharmaceuticals Inc |
Compositions anti-cancéreuses
|
EA035988B1
(ru)
|
2014-12-05 |
2020-09-09 |
Арагон Фармасьютикалз, Инк. |
Противораковые композиции
|
CN104857157A
(zh)
|
2015-05-12 |
2015-08-26 |
四川金堂海纳生物医药技术研究所 |
一种治疗子宫内膜增殖症的汤剂药物及制备方法
|
KR20200070334A
(ko)
|
2017-10-16 |
2020-06-17 |
아라곤 파마슈티컬스, 인코포레이티드 |
비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐
|